Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Senti Biosciences Holdings, Inc.’s names, not what it holds today.
Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and none in 2023
Applications published
37
6 of them in 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology3
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Senti Biosciences, Inc. a former name
named as the applicant on its applications, in US
35 publishedSenti Biosciences, Inc. a former name
US, as the owner printed on each patent
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jun 11, 2024 | 12,005,081 | Chimeric receptors and methods of use thereof | Biotechnology | Senti Biosciences, Inc. |
| Sep 20, 2022 | 11,446,332 | Combinatorial cancer immunotherapy | Pharmaceuticals | Senti Biosciences, Inc. |
| Aug 23, 2022 | 11,419,898 | Combinatorial cancer immunotherapy | Biotechnology | Senti Biosciences, Inc. |
| May 4, 2021 | 10,993,967 | Combinatorial cancer immunotherapy | Biotechnology | Senti Biosciences, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Nov 6, 2025 | 2025/0339534 | INHIBITORY CHIMERIC RECEPTOR ARCHITECTURES | Medical technology | Senti Biosciences, Inc. |
| Sep 25, 2025 | 2025/0297276 | MACROPHAGE-SPECIFIC PROMOTERS AND USES THEREOF | Biotechnology | Senti Biosciences, Inc. |
| Jul 10, 2025 | 2025/0222133 | CELL-TYPE SPECIFIC REGULATORY ELEMENTS FOR PHOTORECEPTORS | Biotechnology | Senti Biosciences, Inc. |
| Feb 6, 2025 | 2025/0041345 | MULTICISTRONIC CHIMERIC PROTEIN EXPRESSION SYSTEMS | Medical technology | Senti Biosciences, Inc. |
| Jan 30, 2025 | 2025/0032548 | ANTIGEN-BINDING DOMAINS AND METHODS OF USE THEREOF | Medical technology | Senti Biosciences, Inc. |
| Jan 9, 2025 | 2025/0011384 | CYTOKINE-IMMUNORECEPTOR FUSION PROTEINS AND USES THEREOF | Biotechnology | Senti Biosciences, Inc. |
| Dec 19, 2024 | 2024/0415891 | ACTIVATION RESPONSIVE PROMOTERS AND USES THEREOF | Medical technology | Senti Biosciences, Inc. |
| Aug 22, 2024 | 2024/0277766 | ARMED CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | Biotechnology | Senti Biosciences, Inc. |
| Aug 22, 2024 | 2024/0277765 | CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | Biotechnology | Senti Biosciences, Inc. |
| Jul 11, 2024 | 2024/0226296 | ERT2 MUTANTS AND USES THEREOF | Medical technology | Senti Biosciences, Inc. |
What it applied for, 2024 to 2025: Medical technology 11 · Biotechnology 8.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.